References
Laboratory Centre for disease Control. Notifiable Diseases Annual Summary 1994. Can Commun Dis Rep. 1996;22:S2.
Laboratory Centre for disease Control. Notifiable Diseases Annual Summary 1995. Can Commun Dis Rep. 1996;22(11):85–86.
Reddy PA, Gupta I, Ganguly NK. Hepatitis B vaccination in pregnancy: safety and immuno-genic response in mothers and antibody transfer to neonates. Asia-Oceania J Obstet Gynaecol 1994;20(4):361–65.
Goldfarb J, Baley J, Medendorp SV, et al. Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonates. Pediatr Infect Dis J 1994;13(1):18–22.
Karpuch J, Eshchar J, Waron M, et al. Vaccination against hepatitis B in a general hospital in Israel: antibody level before vaccination and immunogenicity of vaccine. Isr J Med Sci 1993;29(8):449–52.
Cleveland JL, Siew C, Lockwood SA, et al. Factors associated with hepatitis B vaccine response among dentists. J Dent Res 1994;73(5):1029–35.
Gonzales ML, Gonzales JB, Salva F, Lardinois R. A 7-year follow-up of newborns vaccinated against hepatitis B. Vaccine 1993;11(10):1033–36.
Andre FE. Prevention of the transmission of hepatitis B infection by the sexual route. In: Piot P, Andre FE (Eds.), Hepatitis B: A Sexually Transmitted Disease in Heterosexuals. Proceedings of a Symposium Held in Barcelona. Amsterdam: Elsevier Science Publishers, 1990.
Successful strategies in adult immunization. MMWR 1991;40(41):702–9.
Andre FE, Safary A. Summary of clinical findings on Engerix-B, a genetically engineered yeast-derived hepatitis B vaccine. Postgrad Med J 1987;63(Suppl 2):169–78.
Woolf B. On estimating the relation between blood group and disease. Ann Hum Gen 1955;19:251–53.
Yuan L, Robinson G. Hepatitis B vaccination and screening for markers at a sexually transmitted disease clinic for men. Can J Public Health 1994;85(5):338–41.
Weinstock HS, Bolan G, Moran JS, Peterman TA, et al. Routine hepatitis B vaccination in a clinic for sexually transmitted diseases. Am J Public Health. 1995;85(6):846–49.
Sellors J, Pickard L, Mahony J, et al. Understanding and enhancing compliance with the second dose of hepatitis B vaccine: A cohort analysis and a randomized trial. Can Med Assoc J 1997 (in press).
Marchou B, Excler JL, Bourderioux C, et al. A 3-week hepatitis B vaccination schedule provides rapid and persistent protective immunity: a multicenter, randomized trial comparing accelerated and classic vaccination schedules. J Infect Dis 1995;172(1):258–60.
Marchou B, Picot N, Chavanet P, et al. Threeweek hepatitis B vaccination provides protective immunity. Vaccine 1993;11(14):1383–85.
Santagostino E, Mannucci PM, Gringeri A, et al. Accelerated schedule of hepatitis B vaccination in patients with haemophilia. J Med Virol 1993;41(2):95–8.
Morris DJ, O’ Neil E, McCloy EC, et al. Hepatitis B surface antibody responses following accelerated vaccination (letter). J Hosp Infect 1993;23(4):317–19.
Hay JD, Sellors JW, Pickard L, Gafni A. To vaccinate or not to vaccinate: Economic evaluation of hepatitis B vaccination strategies at an STD clinic. New Orleans: 11th meeting of the International Society for STD Research, 1995 (abstract - poster presentation).
Author information
Authors and Affiliations
Corresponding author
Additional information
Source of support: SmithKline Beecham Pharma Inc., Oakville, Ont.
Rights and permissions
About this article
Cite this article
Sellors, J., Zimic-Vincetic, M., Howard, M. et al. Lack of Compliance with Hepatitis B Vaccination among Canadian STD Clinic Patients: Candidates for an Accelerated Immunization Schedule?. Can J Public Health 88, 210–211 (1997). https://doi.org/10.1007/BF03403890
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03403890